Home  /  Resource Library  /  How should we manage toxicities associated with BTK inhibitors in CLL?

How should we manage toxicities associated with BTK inhibitors in CLL?

Video interview with Nicole Lamanna, who discusses strategies on the management of side effects of BTK inhibitors for treatment of chronic lymphocytic leukemia.